» Articles » PMID: 10783893

NAK is an IkappaB Kinase-activating Kinase

Overview
Journal Nature
Specialty Science
Date 2000 Apr 28
PMID 10783893
Citations 121
Authors
Affiliations
Soon will be listed here.
Abstract

Phosphorylation of IkappaB by the IkappaB kinase (IKK) complex is a critical step leading to IkappaB degradation and activation of transcription factor NF-kappaB. The IKK complex contains two catalytic subunits, IKKalpha and IKKbeta, the latter being indispensable for NF-kappaB activation by pro-inflammatory cytokines. Although IKK is activated by phosphorylation of the IKKbeta activation loop, the physiological IKK kinases that mediate responses to extracellular stimuli remain obscure. Here we describe an IKK-related kinase, named NAK (NF-kappaB-activating kinase), that can activate IKK through direct phosphorylation. NAK induces IkappaB degradation and NF-kappaB activity through IKKbeta. Endogenous NAK is activated by phorbol ester tumour promoters and growth factors, whereas catalytically inactive NAK specifically inhibits activation of NF-kappaB by protein kinase C-epsilon (PKCepsilon). Thus, NAK is an IKK kinase that may mediate IKK and NF-kappaB activation in response to growth factors that stimulate PKCepsilon activity.

Citing Articles

TBK1 and IKKε prevent premature cell death by limiting the activity of both RIPK1 and NLRP3 death pathways.

Fischer F, Demarco B, Min F, Yeap H, De Nardo D, Chen K Sci Adv. 2025; 11(10):eadq1047.

PMID: 40053580 PMC: 11887814. DOI: 10.1126/sciadv.adq1047.


Adaptor-Mediated Trafficking of Tank Binding Kinase 1 During Diverse Cellular Processes.

Paul S, Biswas S, Milner J, Tomsick P, Pickrell A Traffic. 2025; 26(1-3):e70000.

PMID: 40047067 PMC: 11883510. DOI: 10.1111/tra.70000.


Optimizing Niclosamide for Cancer Therapy: Improving Bioavailability via Structural Modification and Nanotechnology.

Wiggins R, Woo J, Mito S Cancers (Basel). 2024; 16(20).

PMID: 39456642 PMC: 11506536. DOI: 10.3390/cancers16203548.


Mechanism of TBK1 activation in cancer cells.

Hu L, Zhang Q Cell Insight. 2024; 3(5):100197.

PMID: 39279883 PMC: 11402294. DOI: 10.1016/j.cellin.2024.100197.


Suppression of smooth muscle cell inflammation by myocardin-related transcription factors involves inactivation of TANK-binding kinase 1.

Bankell E, Liu L, van der Horst J, Rippe C, Jepps T, Nilsson B Sci Rep. 2024; 14(1):13321.

PMID: 38858497 PMC: 11164896. DOI: 10.1038/s41598-024-63901-3.